BWX Technologies reported Q2 2026 results ahead of expectations with revenue of $901.6 million up 18 percent year over year, adjusted EBITDA of $155.5 million up 7 percent, and non-GAAP EPS of $1.07 up 5 percent. Government Operations grew 2 percent to $601.3 million while Commercial Operations surged 72 percent to $302.5 million driven by commercial nuclear components, field services, fuel handling, medical, and the Kinectrics contribution. The company announced the sale of its medical business to increase focus on nuclear national security and commercial nuclear power, and closed the Precision Components Group acquisition on July 1, 2026 establishing a U.S. footprint for commercial nuclear component manufacturing. Full-year guidance was raised to $3.8 billion revenue, $662-672 million adjusted EBITDA, $4.70-4.80 non-GAAP EPS, and $345-360 million free cash flow.
The investment thesis rests on three variables. The commercial nuclear growth and the component manufacturing localization is the load-bearing revenue variable, with Commercial Operations revenue up 72 percent to $302.5 million, the PCG acquisition adding U.S. commercial nuclear component capacity, and the strategic intent is to capture the nuclear renaissance demand for domestic component manufacturing, and the market will track quarterly Commercial Operations growth, PCG integration revenue, new plant component orders, and field services demand as real-time indicators. The government operations stability and the naval propulsion backlog is the load-bearing margin variable, with Government Operations at $601.3 million and adjusted EBITDA of $126.5 million, the strategic intent is to maintain the predictable naval reactor and special materials revenue streams while managing contract adjustments, and the market will track quarterly Government Operations margin, naval propulsion contract awards, special materials demand, and technical services equity income as real-time indicators. The free cash flow conversion and the capital allocation discipline is the load-bearing shareholder value variable, with free cash flow of $115.0 million in Q2, guidance raised to $345-360 million for the year, $0.27 quarterly dividend, and the strategic intent is to deploy cash toward nuclear growth investments while maintaining dividend growth, and the market will track quarterly free cash flow, capital expenditure efficiency, dividend increases, and share repurchase activity as real-time indicators.